Skip to main content
Top
Gepubliceerd in:

15-02-2023

Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs

Auteurs: Mehmet Akif Erişen, Fatma Özlem Yılmaz

Gepubliceerd in: Quality of Life Research | Uitgave 7/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

In this study, it was aimed to compare the administration of chemotherapy drugs via venous port catheter and peripheral vein in metastatic colon cancer patients in terms of quality of life and treatment costs.

Methods

The research was carried out in a university hospital in Turkey. The population of the study consists of 130 patients with metastatic colon cancer who were treated with chemotherapy. The sample of the study consists of 103 participants. During the data collection phase of the study, three data collection tools were used: demographic information form, EOTC QLQ-30 quality of life scale and invoices for treatments. Data were analyzed using Microsoft Office Excel and IBM SPSS 20 package programs.

Results

In the study, 71.8% of the participants received chemotherapy with a venous port catheter, 65% for more than 3 months, 56.3% in the day unit. As a result of the study, it was found that there were no significant differences in the quality of life (except social function) according to the chemotherapy method. In addition, when the research results are examined in terms of cost, statistically significant differences were found in the treatment cost (except total costs excluding drugs) according to the chemotherapy application method.

Conclusion

In line with these results, it is thought that when choosing the chemotherapy application method, factors such as the treatment duration of the patients, the ease of opening the vascular access, and the patient's psychological state should be taken into consideration.
Literatuur
1.
go back to reference The Ministry of Health of Turkey. (2021). Health statistics yearbook 2019. Publication no: 1186, General Directorate of Health Information Systems, Ankara. The Ministry of Health of Turkey. (2021). Health statistics yearbook 2019. Publication no: 1186, General Directorate of Health Information Systems, Ankara.
2.
go back to reference Cabı Ünal, E. (2009). Port uygulamaları. In İ İlhan & T. Kutluk (Eds.), Pediatrik onkoloji el kitabı (pp. 79–90). Türk Pediatri Onkoloji Grubu. Cabı Ünal, E. (2009). Port uygulamaları. In İ İlhan & T. Kutluk (Eds.), Pediatrik onkoloji el kitabı (pp. 79–90). Türk Pediatri Onkoloji Grubu.
9.
go back to reference Whynes, D. K., Neilson, A. R., Robinson, M. H. E., & Hardcastle, J. D. (1994). Colorectal cancer screening and quality of life. Quality of Life Research, 3(3), 191–198.CrossRefPubMed Whynes, D. K., Neilson, A. R., Robinson, M. H. E., & Hardcastle, J. D. (1994). Colorectal cancer screening and quality of life. Quality of Life Research, 3(3), 191–198.CrossRefPubMed
17.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. https://doi.org/10.1093/jnci/85.5.365CrossRefPubMed Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. https://​doi.​org/​10.​1093/​jnci/​85.​5.​365CrossRefPubMed
18.
go back to reference Beser, N., & Öz, F. (2003). Anxiety-depression levels and quality of life of patients with lymphoma who are curing chemotherapy. Journal of Cumhuriyet University School of Nursing, 7(1), 47–58. Beser, N., & Öz, F. (2003). Anxiety-depression levels and quality of life of patients with lymphoma who are curing chemotherapy. Journal of Cumhuriyet University School of Nursing, 7(1), 47–58.
19.
go back to reference Fayers, P. M. A. N., Aaronson, N., Bjordal, K., Groenvold, M., Curran, D., et al. (2001). EORTC QLQ-C30 Scoring Manual (3 Edn). Fayers, P. M. A. N., Aaronson, N., Bjordal, K., Groenvold, M., Curran, D., et al. (2001). EORTC QLQ-C30 Scoring Manual (3 Edn).
20.
go back to reference Plichta, S. B., & Kelvin, E. A. (2013). Munro's statistical methods for health care research. Wolters Kluwer Health/Lippincott Williams & Wilkins. Plichta, S. B., & Kelvin, E. A. (2013). Munro's statistical methods for health care research. Wolters Kluwer Health/Lippincott Williams & Wilkins.
24.
go back to reference Isaksen, A. S., & Gjengedal, E. (2000). The significance of fellow patients for the patient with cancer: What can nurses do? Cancer Nursing, 23(5), 382–391.CrossRefPubMed Isaksen, A. S., & Gjengedal, E. (2000). The significance of fellow patients for the patient with cancer: What can nurses do? Cancer Nursing, 23(5), 382–391.CrossRefPubMed
25.
go back to reference Anderson, H., Addington-Hall, J. M., Peake, M. D., McKendrik, J., Keane, K., et al. (2003). Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: Results of a feasibility study. British Journal of Cancer, 89(12), 2190–2196.CrossRefPubMedPubMedCentral Anderson, H., Addington-Hall, J. M., Peake, M. D., McKendrik, J., Keane, K., et al. (2003). Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: Results of a feasibility study. British Journal of Cancer, 89(12), 2190–2196.CrossRefPubMedPubMedCentral
28.
go back to reference Vokes, E. E., Schilsky, R. L., Choi, K. E., Magid, D. M., Guarnieri, C. M., et al. (1989). A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer, 63(1), 30–36.CrossRefPubMed Vokes, E. E., Schilsky, R. L., Choi, K. E., Magid, D. M., Guarnieri, C. M., et al. (1989). A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer, 63(1), 30–36.CrossRefPubMed
30.
go back to reference Brown, D. F., Muirhead, M. J., Travis, P. M., Vire, S. H., Weller, J., et al. (1997). Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer, 80(5), 966–972.CrossRefPubMed Brown, D. F., Muirhead, M. J., Travis, P. M., Vire, S. H., Weller, J., et al. (1997). Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer, 80(5), 966–972.CrossRefPubMed
31.
go back to reference Herrmann, R. P., Trent, M., Cooney, J., & Cannel, P. K. (1996). Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplantation, 24(11), 1213–1217.CrossRef Herrmann, R. P., Trent, M., Cooney, J., & Cannel, P. K. (1996). Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplantation, 24(11), 1213–1217.CrossRef
32.
34.
go back to reference Vinciguerra, V., Degnan, T. J., Sciortino, A., O’Connell, M., Moore, T., et al. (1986). A comparative assessment of home versus hospital comprehensive treatment for advanced cancer patients. Journal of Clinical Oncology, 4(10), 1521–1528.CrossRefPubMed Vinciguerra, V., Degnan, T. J., Sciortino, A., O’Connell, M., Moore, T., et al. (1986). A comparative assessment of home versus hospital comprehensive treatment for advanced cancer patients. Journal of Clinical Oncology, 4(10), 1521–1528.CrossRefPubMed
37.
go back to reference Larsen, F. O., Christiansen, A. B., Rishøj, A., Nelausen, K. M., & Nielsen, D. L. (2018). Safety and feasibility of home-based chemotherapy. Danish Medical Journal, 65(5), 1–5. Larsen, F. O., Christiansen, A. B., Rishøj, A., Nelausen, K. M., & Nielsen, D. L. (2018). Safety and feasibility of home-based chemotherapy. Danish Medical Journal, 65(5), 1–5.
40.
go back to reference Department of Health Cancer Policy Team. (2010). Chemotherapy services in the community: A guide for PCTs. DH. Department of Health Cancer Policy Team. (2010). Chemotherapy services in the community: A guide for PCTs. DH.
43.
go back to reference Corrie, P. G., Moody, M., Wood, V., Bavister, L., Prevost, T., et al. (2011). Protocol for the OUTREACH trial: A randomised trial comparing delivery of cancer systemic therapy in three different settings-patient’s home, GP surgery and hospital day unit. BMC Cancer, 11(1), 1–10.CrossRef Corrie, P. G., Moody, M., Wood, V., Bavister, L., Prevost, T., et al. (2011). Protocol for the OUTREACH trial: A randomised trial comparing delivery of cancer systemic therapy in three different settings-patient’s home, GP surgery and hospital day unit. BMC Cancer, 11(1), 1–10.CrossRef
44.
go back to reference Hirtzlin, I., & Préaubert-Hayes, N. (2005). In-hospital and at-home cancer chemotherapy: A comparison of costs and organisation of care. HEaPHD, Haute Autorité de Santé. Hirtzlin, I., & Préaubert-Hayes, N. (2005). In-hospital and at-home cancer chemotherapy: A comparison of costs and organisation of care. HEaPHD, Haute Autorité de Santé.
Metagegevens
Titel
Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs
Auteurs
Mehmet Akif Erişen
Fatma Özlem Yılmaz
Publicatiedatum
15-02-2023
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-023-03365-6

Andere artikelen Uitgave 7/2023

Quality of Life Research 7/2023 Naar de uitgave